Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01089062 · ClinicalTrials.gov registry record · Phase 1

Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure

A Phase 1 study of Healthy, sponsored by Allergan.

Completed
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT01089062 is a Phase 1 study of Healthy that has completed, run by Allergan. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01089062, a Phase 1 study of Healthy, has completed, sponsored by Allergan.

COMPLETED
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

Compare the acute effects and tolerability of Dihydroergotamine Mesylate (DHE) delivered by Oral Inhalation (MAP0004) versus by intravenous (IV) infusion in healthy adult volunteers.

Conditions Studied

Healthy

Interventions

  • DRUG MAP0004
  • DRUG IV Placebo (Saline)
  • DRUG Placebo Inhaler
  • DRUG IV Dihydroergotamine Mesylate (DHE)

Study Locations (1)

North Carolina

  • Duke Clinical Research Unit - Durham

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2010-03
Est. Completion 2010-12
Phase Phase 1

Sponsor

Allergan

314 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01089062

The ClinicalTrials.gov registry entry for NCT01089062 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which MAP0004 is the first listed.

NCT01089062 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01089062 about?

NCT01089062 is a clinical study titled "Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure". Compare the acute effects and tolerability of Dihydroergotamine Mesylate (DHE) delivered by Oral Inhalation (MAP0004) versus by intravenous (IV) infusion in healthy adult volunteers.

What is the current status of trial NCT01089062?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2010-03. Estimated completion is 2010-12.

What conditions does trial NCT01089062 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT01089062?

The interventions under investigation include: MAP0004 (DRUG), IV Placebo (Saline) (DRUG), Placebo Inhaler (DRUG), IV Dihydroergotamine Mesylate (DHE) (DRUG).

Who is sponsoring clinical trial NCT01089062?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01089062 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.